GCG and type 2 diabetes mellitus: However, as many as 50% of patients with T2DM remain hyperglycemic after lifestyle modification and pharmacologic monotherapy interventions, and for those patients, guidelines recommend the addition of a second agent, such as a glucagon-like peptide-1 (GLP-1) receptor agonist [8].